Neuropsychological assessment of paediatric brain tumour survivors: Factors associated with assessment
- PMID: 34014589
- DOI: 10.1111/jpc.15568
Neuropsychological assessment of paediatric brain tumour survivors: Factors associated with assessment
Abstract
Aim: Paediatric brain tumour survivors are at increased risk of neurocognitive deficits that affect their education. The aim of this study was to assess the proportion of brain tumour survivors who historically received a neuropsychological assessment and examine the demographic and treatment-related variables associated with neuropsychological assessment. A further aim was to determine the number and treatment profile of brain tumour survivors who would benefit from neuropsychological assessment.
Methods: Data from the New Zealand Children's Cancer Registry including treatments received, was used to identify children treated for a brain tumour at Starship Children's Hospital between January 2009 and December 2015. Clinical records were examined for evidence of a neuropsychological assessment in the form of a written report. Logistic regression models were used to determine factors associated with receipt of an assessment.
Results: Of the 132 brain tumour survivors, 37 (28.0%) had evidence of a neuropsychological assessment in their clinical records. In adjusted analysis, children who were treated with all three of surgery, chemotherapy and radiotherapy (n = 38) were more likely to have had an assessment (odds ratio: 12.90; 95% confidence interval: 4.76-34.93) than children who had either no treatment, chemotherapy alone, surgery alone or chemotherapy and surgery (n = 73). Treatment with radiotherapy alone or with either chemotherapy or surgery (n = 21) was not significantly associated with receipt of assessment (odds ratio = 2.40; 95% confidence interval: 0.69-8.37).
Conclusions: It is important to identify the number of children who might benefit from neuropsychological assessment to inform prioritisation within existing resource and plan for additional resource if required. With a focus on reducing late effects, it is imperative that neuropsychological assessment is an integral component of a paediatric brain tumour programme.
Keywords: brain tumour; late effects; neuropsychological assessment.
© 2021 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).
References
-
- De Luca C. A Compendium of Evidence and Framework for Neuropsychological Services in Paediatric Cancer. Victoria, Australia: Pediatric Integrated Care Service; 2015.
-
- Postal K, Chow C, Jung S, Erickson-Moreo K, Geier F, Lanca M. The stakeholders' project in neuropsychological report writing: A survey of neuropsychologists' and referral sources' views of neuropsychological reports. Clin. Neuropsychol. 2018; 32: 326-44.
-
- Donders J. Pediatric neuropsychological reports: Do they really have to be so long? Child Neuropsychol. 1999; 5: 70-8.
-
- Butler RWHJ. Neurocognitive effects of treatment for childhood cancer. Ment. Retard. Dev. Disabil. Res. Rev. 2006; 12: 184-91.
-
- Turner CD, Rey-Casserly C, Liptak CC, Chordas C. Late effects of therapy for pediatric brain tumor survivors. J. Child Neurol. 2009; 24: 1455-63.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
